Julia F. Lenz-Brosch

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Dynamics, Pharmacokinetics, and Dosimetry of First-in-Human [68Ga]Ga-OncoACP3-DOTA PET in Patients with Prostate Cancer.

Dynamics, Pharmacokinetics, and Dosimetry of First-in-Human [68Ga]Ga-OncoACP3-DOTA PET in Patients with Prostate Cancer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: December 19, 2025

Pulling Together: A 5-Year Plan to Improve Theranostic Outcomes by Improving the Accuracy of Dosimetry-An FNIH Joint Academic, Clinical, and Industrial Collaboration.

Pulling Together: A 5-Year Plan to Improve Theranostic Outcomes by Improving the Accuracy of Dosimetry-An FNIH Joint Academic, Clinical, and Industrial Collaboration.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: November 17, 2025

Estimation of split renal function using [18F]-flotufolastat PET/CT compared with [68Ga]-PSMA-11 and [99mTc]-MAG3 scintigraphy.

Estimation of split renal function using [18F]-flotufolastat PET/CT compared with [68Ga]-PSMA-11 and [99mTc]-MAG3 scintigraphy.

Journal: EJNMMI research

Published: September 17, 2025

[99mTc]Tc-PSMA-HSG for PSMA-targeted Hybrid Surgical Guidance: a new addition to the PSMA-I&S/I&T family.

[99mTc]Tc-PSMA-HSG for PSMA-targeted Hybrid Surgical Guidance: a new addition to the PSMA-I&S/I&T family.

Journal: European journal of nuclear medicine and molecular imaging

Published: September 16, 2025

Translational and First-in-Human Positron Emission Tomography Targeting Prostatic Acid Phosphatase in Prostate Cancer Using the Ligand [68Ga]Ga-OncoACP3-DOTA.

Translational and First-in-Human Positron Emission Tomography Targeting Prostatic Acid Phosphatase in Prostate Cancer Using the Ligand [68Ga]Ga-OncoACP3-DOTA.

Journal: European urology

Published: September 11, 2025

An international study of factors affecting variability of dosimetry calculations, part 5: impact of segmentation methods.

An international study of factors affecting variability of dosimetry calculations, part 5: impact of segmentation methods.

Journal: EJNMMI physics

Published: July 18, 2025

Biodistribution and Radiation Dosimetry of [68Ga]Ga-RAYZ-8009, a Glypican 3-Targeting Compound for Imaging of Hepatocellular Carcinoma.

Biodistribution and Radiation Dosimetry of [68Ga]Ga-RAYZ-8009, a Glypican 3-Targeting Compound for Imaging of Hepatocellular Carcinoma.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: April 25, 2025

[225Ac]Ac-PSMA I&T: A Preclinical Investigation on the Fate of Decay Nuclides and Their Influence on Dosimetry of Salivary Glands and Kidneys.

[225Ac]Ac-PSMA I&T: A Preclinical Investigation on the Fate of Decay Nuclides and Their Influence on Dosimetry of Salivary Glands and Kidneys.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: February 18, 2025

[225Ac]Ac-PSMA I&T: A Preclinical Investigation on the Fate of Decay Nuclides and Their Influence on Dosimetry of Salivary Glands and Kidneys.

[225Ac]Ac-PSMA I&T: A Preclinical Investigation on the Fate of Decay Nuclides and Their Influence on Dosimetry of Salivary Glands and Kidneys.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: February 18, 2025

Randomized Phase 2 Trial of an Extended and Flexible Dosing Schedule of 177Lu-PSMA Molecular Radiotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT): Study Protocol.

Randomized Phase 2 Trial of an Extended and Flexible Dosing Schedule of 177Lu-PSMA Molecular Radiotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT): Study Protocol.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: January 08, 2025

Recommendations for Standardizing Nuclear Medicine Terminology and Data in the Era of Theranostics and Artificial Intelligence.

Recommendations for Standardizing Nuclear Medicine Terminology and Data in the Era of Theranostics and Artificial Intelligence.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: December 23, 2024

Dosimetry Software for Theranostic Applications: Current Capabilities and Future Prospects.

Dosimetry Software for Theranostic Applications: Current Capabilities and Future Prospects.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: October 16, 2024

Showing 1-12 of 38

Last Updated: 09/26/2026